Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Stopped early · Not applicable

Conditions studied: Uterine Cervical Neoplasm

In brief

The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.

Key facts

Study ID
NCT03020121
Run by
Becton, Dickinson and Company
People needed
28
Starts
2016-11-01
Expected to finish
2017-05-01
Last updated by the study team
2018-01-31

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.